Member Info for hahahehehoho

UK must be one of the worst countries to put money into a pension in as it such a broken system. I'm guessing the Nordic countries or Asian tiger economies like Singapore , for pensions the return must be amazing. Instead of a UK pension., Just stick it eua imo

Yup, dvrg depend on avacta. I know that, and avacta will most likely take all the profit from them. Win all round.

Well said red, aptamer /affimer testing v conventional PCR testing will throw up completely different results, and will confuse common ppl. For Aptamer / affimer testing , it will take time for this to be accepted as the industry norm. avct, dvrg, brh, etc are all the right area for next generation testing growth though.

Monks, must be a reason why the ceo sold £400ks worth. Seems like test not coming to full market out anytime soon, at this rate BRH's Paraytecs test will be out before Avactas.

Alistair Smith, Avacta’s chief executive, said the price of the test would probably be similar to a commercial HIV test, which cost about $30 (£25), but would be lower if health organisations or businesses bought it in bulk. The company said it had had inquiries from firms that wanted to test staff to ensure they are healthy before they return to work.

Pricing is not up to us. That is what Avacata have said about the price range of £25 before

*20 min test i meant

£5 is perfectly pitched imho

avcts 10 mi test is around £25 as clearly stated in the summer

Obviously the CEO would not have sold any if there was a test coming in November. I'd say Jan Feb is nailed on for the test to go for mass market (as long as it is approved)

Feel free to offload at 48p. IF trials are successful and big partnerships are formed. The SP is basically going warp speed to 500p+

https://www.flytesofancy.co.uk/chickenhouses/Poultry-Feeds-Grit.html

Boohoo unfortunately get the bad end of the stick when it comes to bad news. Bad news -30%>>. Good news +5%, no news, slow recovery up .
Is the market racist or something? 8-p

Looks tempting to buy this but no cash :-(

Heimlich, you should research " intact virus" before jumping the gun. There must be absolutely no reason why avct is valued at £450m after all. I'll leave it there. ;-)

Yup I'm afraid so. It is a shocking number but some if I remember, say up to 93% , there are differing opinions on this but the general consensus among the scientific community agree it is pointless detecting dead uninintact viruses in a patient's body and classify and include it as a positive in the statistics.

Nothing is safer than houses in this environment especially with stamp duty being nothing .

Goliath, I have been a holder in avacta since the 60s on and off. The difference is that avct can detect the intact virus instead of fragments of the dead virus which remain in people's bodies for a long time. Of the people who test positive , a whopping 90% of them are false positives when done on PCR/POC . It's all part of the next generation of testing next year . Atampter group, dvrg, brh, avct all part of the next wave. As for genedrive they need to be a part of this, but for now gdr is quite a easy to make money from trading but not as a serious investment.

I think if Carl's test comes good it is 100000 times the game changer the masks are. The MMs as you know are unpredictable

37p now. Are MMs going to walk this down ?

https://www.telegraph.co.uk/business/2020/10/19/government-bought-ppe-firms-linked-chinese-state/